保定市百白破疫苗与二价脊灰疫苗同时接种不良反应比较  

Comparison of adverse reactions of simultaneous vaccination of diphtheria tetanus and pertussis vaccine and bivalent poliomyelitis vaccine in Baoding City

作　　者：纪磊 马继飞[1] 崔立周[1] 吴冰冰[1] 魏鹏飞 左志平[1] JI Lei;MA Jifei;CUI Lizhou;WU Bingbing;WEI Pengfei;ZUO Zhiping(Baoding Center for Disease Control and Prevention,Baoding,Hebei 071000,China)

机构地区：[1]保定市疾病预防控制中心,河北保定071000

出　　处：《医学动物防制》2024年第11期1070-1074,共5页Journal of Medical Pest Control

基　　金：河北省2024年度医学研究课题计划(20242315);河北省提前下达2022年中央财政重大传染病防控项目(冀财社[2021]169号)。

摘　　要：目的评价2016—2019年保定市适龄儿童无细胞百白破联合疫苗(diphtheria tetanus and acellular pertussis combined vaccine,DTaP)与二价口服脊髓灰质炎减毒活疫苗(bivalent oral poliomyelitis attenuated live vaccine,bOPV)(简称“二价脊灰疫苗”)同时接种的安全性。方法采用描述性方法计算两种疫苗单独和同时接种不良反应的报告发生率、构成比等流行病学相关指标,用SPSS 22统计软件进行指标的分析比较。结果DTaP单独接种、bOPV单独接种、DTaP和bOPV同时接种不良反应发生率分别为169.74/10万剂、14.34/10万剂、17.84/10万剂,一般反应发生率分别为168.31/10万剂、13.49/10万剂、17.12/10万剂,异常反应发生率分别为1.42/10万剂、0.85/10万剂、0.72/10万剂。DTaP和bOPV同时接种与DTaP单独接种不良反应、一般反应、异常反应的发生率的比较,差异有统计学意义(χ^(2)=4316.267、4302.705、19.282,P<0.05);DTaP和bOPV同时接种与bOPV单独接种不良反应、一般反应的报告发生率比较,差异有统计学意义(χ^(2)=91.310、89.949,P<0.05),异常反应的发生率比较,差异无统计学意义(χ^(2)=1.862,P>0.05)。结论DTaP和bOPV同时接种未明显增加不良反应的发生风险和严重程度,安全性良好。DTaP和bOPV同时接种可提高疫苗接种的及时性,应加强宣教以提高疫苗接种的依从性,同时做好疫苗接种前儿童健康评估。Objective To evaluate the safety of simultaneous vaccination of diphtheria tetanus and acellular pertussis combined vaccine(DTaP)and bivalent oral poliomyelitis attenuated live vaccine(bOPV)(referred to as bivalent polio vaccine)for eligible children in Baoding City from 2016 to 2019.Methods The epidemiological correlative indexs related to the reported incidence rate and proportion of adverse reactions to the two vaccines alone and concurrently were calculated by a descriptive method.The indicators were analyzed and compared using SPSS 22 statistical software.Results The incidence rates of adverse reactions after vaccination with DTaP alone,bOPV alone,DTaP and bOPV simultaneously were 169.74/100000 doses,14.34/100000 doses,and 17.84/100000 doses,respectively.The incidence rates of general reactions were 168.31/100000 doses,13.49/100000 doses,17.12/100000 doses,respectively.The incidence rates of abnormal reactions were 1.42/100000 doses,0.85/100000 doses,0.72/100000,respectively.There were statistically significant differences in the incidence rates of adverse reactions,general reactions,and abnormal reactions between simultaneous vaccination of DTaP and bOPV and separate vaccination of DTaP(χ^(2)=4316.267,4302.705,19.282,P<0.05).There were statistically significant differences in the reported incidence rates of adverse reactions and general reactions between simultaneous vaccination of DTaP and bOPV and separate vaccination of bOPV(χ^(2)=91.310,89.949,P<0.05),while there was no statistically significant difference in the incidence rate of abnormal reactions(χ^(2)=1.862,P>0.05).Conclusion Simultaneous vaccination of DTaP and bOPV do not obviously increase the risk and severity of adverse reactions,and the safety profile is good.Simultaneous vaccination of DTaP and bOPV can improve the timeliness of vaccination,and education should be strengthened to increase adherence to vaccination.At the same time,meanwhile,the health assessments of children should be conducted before vaccination.

关 键 词：无细胞百白破联合疫苗 二价口服脊髓灰质炎减毒活疫苗 同时接种 不良反应 安全性 

分 类 号：R392.1[医药卫生—免疫学]